share_log

Biora Therapeutics Says On Jan. 19, 2023 Co. Received Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard From Nasdaq

Benzinga Real-time News ·  Jan 20, 2023 16:12
Biora Therapeutics Says On Jan. 19, 2023 Co. Received Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard From Nasdaq
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment